Introduction Impairment of gastric motility is frequently encountered inthe intensive care unit (ICU) due to a multitude of factors. Although gastric emptying may beimpaired, small bowel absorptive capacity is often preserved. Early enteralfeeding to ICU patients may prevent translocation of bacteria and endotoxin,and stress ulcers, and so the promotion of gastric emptying is to be encouraged.Metoclopramide is a prokinetic agent which may be useful in this setting.
Aims
To assess whether metoclopramide improves gastric motility in thecritically ill.
Methods
Over a two day period, 10 patients receiving enteral feed on the ICUwere randomised to receive 10 mg metoclopramide IV or placebo on the firstday, followed by placebo or metoclopramide on day two. Administration of the studydrug coincided with the commencement of nasogastric feeding for a 5 hperiod, and gastric emptying was assessed on each day by measuring the areaunder the plasma paracetamol absorption curve at 120 min (AUC120) followinga 1.5 g bolus of paracetamol nasogastrically. Gastric aspirates and pH weremeasured before administration of the study drug and at the end of the feedingperiod. Other factors that may have affected gastricemptying were controlled for during the trial period.
Results
Following metoclopramide there was a significant increase ingastric emptying when comparisons of AUC120 were made, although residualgastric aspirates did not correlate with this increase in gastric emptying.
Discussion
Interestingly those patients who were given metoclopramide onday one had greater AUC120 following saline than the other group, suggestingthat the clinical effect of metoclopramide may last longer than its knownpharmacological effect. High residual gastric aspirates do not necessarilymean absent gastric motility. In the critically ill the prokinetic effectsof intravenous metoclopramide are maintained.
